In two late-stage trials of Lilly’s tirzepatide, participants lost one-quarter of their weight
Eli Lilly said its weight loss titan tirzepatide helped people lose up to 26% of their body weight, on average, across two late-stage clinical trials …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
